Radicava

Radicava ORS Warnings and Precautions

• Hypersensitivity reactions: Anaphylaxis and other allergic reactions have occurred; symptoms should be monitored for, especially in patients with a history of drug allergies.
• Sulfite allergy: Radicava ORS contains sodium bisulfite, which may cause allergic-type reactions in susceptible people.
• Fasting requirement: Must be taken after overnight fasting to ensure proper absorption; food should be avoided for 1 hour afterward.

How to Access Radicava ORS in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Radicava ORS to India?

Radicava ORS (edaravone) oral suspension may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified neurologist
• The patient's diagnostic reports confirming ALS
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Radicava ORS available in India?

Radicava ORS (edaravone oral suspension) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Radicava ORS is not commercially marketed in India.

However, patients in India can legally access Radicava ORS through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Radicava ORS received US FDA approval for the treatment of ALS, ensuring full transparency throughout the process.

Radicava ORS can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

For ALS patients with a confirmed SOD1 gene mutation, NPP also facilitates access to Qalsody, a genetically targeted ALS therapy, based on the treating neurologist's assessment.

Sourcing & Delivery of Radicava ORS

Radicava ORS is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained upright at 15°C to 30°C, protected from light
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Radicava ORS Across Major Cities in India

Named Patient Program supports access to Radicava ORS for patients with ALS across major cities in India, coordinating documentation, sourcing, and delivery with treating neurologists.

Mumbai

Patients in Mumbai can access Radicava ORS through NPP with support from treating neurologists at the city's leading ALS care centers.

Delhi

In Delhi, NPP coordinates with hospitals and specialty neurology clinics to facilitate timely access to Radicava ORS.

Bangalore

Bangalore's neurology centers work with NPP to support patients requiring Radicava ORS.

Chennai

Patients in Chennai can access Radicava ORS through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's neurology centers support diagnosis and access coordination for Radicava ORS through NPP.

Kolkata

NPP facilitates access to Radicava ORS for patients in Kolkata under the guidance of treating neurologists.

Pune

Patients in Pune can access Radicava ORS through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Radicava ORS for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Radicava ORS through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Radicava ORS for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Radicava ORS through NPP with support from treating neurologists.

Lucknow

NPP facilitates access to Radicava ORS for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Radicava ORS through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Radicava ORS for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.